Quinaldic Acid

Quinaldic Acid

SCHEMBL6505548

O=C(Cl)c1ccc2ccccc2n1.O=C(O)c1ccc2ccccc2n1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.82
CNR2 P34972 2/20 0.59
SMN1; SMN2 Q16637 6/20 0.58
RAB9A P51151 4/20 0.58
NFKB1 P19838 2/20 0.58
NFKB2 Q00653 2/20 0.58
RELA Q04206 2/20 0.58
ALDH1A1 P00352 6/20 0.55
KMT2A Q03164 5/20 0.55
HPGD P15428 4/20 0.55
MEN1 O00255 4/20 0.55
NPC1 O15118 3/20 0.55
TP53 P04637 3/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
HDAC8 Q9BY41 1/20 0.54
MAPT P10636 3/20 0.53
GAA P10253 2/20 0.53
KDM4C Q9H3R0 1/20 0.51
KDM4E B2RXH2 7/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL335075 0.93 MGAM (0.68) MGAMCNR2SMN1; SMN2RAB9ANFKB1
SCHEMBL30835890 0.93 MGAM (0.68) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Hydrochloric Acid SCHEMBL9524735 0.91 MGAM (0.66) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Quinaldic Acid SCHEMBL1242670 0.91 MGAM (1.00) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Quinaldic Acid SCHEMBL29350584 0.91 MGAM (1.00) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Quinaldic Acid SCHEMBL39024 0.91 MGAM (1.00) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Quinaldic Acid SCHEMBL4588314 0.89 MGAM (0.96) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Quinaldic Acid SCHEMBL5228655 0.89 MGAM (0.96) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Quinaldic Acid SCHEMBL8798794 0.89 MGAM (0.96) MGAMCNR2SMN1; SMN2RAB9ANFKB1
Quinaldic Acid SCHEMBL4802724 0.89 MGAM (0.96) MGAMCNR2SMN1; SMN2RAB9ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005113522-A1 AZOLE CARBOXAMIDE INHIBITORS OF BACTERIAL TYPE III PROTEIN SECRETION SYSTEMS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-12-01 WO disclosed
WO-2005018541-A2 COX-2 INHIBITOR AND SEROTONIN MODULATOR FOR TREATING CNS DAMAGE PHARMACIA CORPORATION (US) 2005-03-03 WO disclosed